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a b s t r a c t
Cadmium is an environmental pollutant that is closely linked with cardiovascular diseases, such as
atherosclerosis and hypertension. Moreover, cadmium can induce an increase in oxidative stress. One of
the main sites affected by oxidative stress is the aorta, which consequently develops atherosclerosis.
However, there are few reports demonstrating aortic effects induced by small concentrations of cadmium
that are similar to those found in the blood resulting from occupational exposure. Furthermore, several
studies have reported on chronic cadmium exposure, and the results of these studies may have been
inﬂuenced by the secondary effects induced by this metal, such as hypertension. Therefore, we
investigated the effects of acute cadmium exposure on the vascular reactivity to phenylephrine of aortic
rings isolated from male Wistar rats. Cadmium increased phenylephrine reactivity without changing the
vasorelaxation induced by acetylcholine and sodium nitroprusside. Endothelial damage or incubation
with L-NAME shifted the phenylephrine concentration–response curves leftward in arteries incubated
with or without cadmium, but the curves were shifted to a lesser degree after cadmium incubation.
Enalapril, losartan, the nonselective COX inhibitor indomethacin, the TXA(2) synthase inhibitor
furegrelate, the selective COX-2 inhibitor NS 398, the TP receptor antagonist SQ 29.548, the EP1 receptor
antagonist SC 19.220, superoxide dismutase, and the NADPH oxidase inhibitor apocynin partially
reverted the cadmium-induced effects on the reactivity to phenylephrine. Cadmium exposure increased
vasoconstrictor activity by reducing NO bioavailability owing to the increased production of ROS by
NADPH oxidase. The results of the tested cadmium concentration, which is below the reference values,
suggest that acute cadmium exposure may induce vascular injury through endothelial oxidative stress.
These data contribute to the evidence indicating that cadmium is a high risk to public health.
& 2013 Elsevier Inc. All rights reserved.
Cadmium is a highly toxic metal and composes part of the earth′s
crust. It is found as a mineral combined with other elements, such as
oxygen, chlorine, or sulfur. Humans and animals are exposed to it via
a variety of routes, including industrial contamination, food sources,
and tobacco smoke [1,2].
Cadmium poses serious risks to human health and affects
several organs and systems [3]. Chronic exposure to this metal
can cause adverse effects in the kidneys, liver, lung, pancreas,
testes, placenta, and bone. Cadmium is an identiﬁed risk factor for
cardiovascular diseases in humans [4–6], and the vascular
endothelium is a target for cadmium toxicity [7,8]. Several studies
that involved the cross-sectional analysis of data from the National
Health and Nutrition Examination Surveys investigated the
association between blood and urine cadmium levels and cardio-
vascular effects [9,10]. Furthermore, in vitro (cell culture) and
in vivo studies have implicated cadmium as an environmental
factor that is toxic to the vascular endothelium and the smooth
muscle component of the vascular wall [11].This effect seems to
involve, at least in part, a reduction in nitric oxide (NO) bioavail-
ability, as suggested by [12]. Recently, we also demonstrated that
chronic cadmium exposure reduces NO bioavailability, probably
owing to increased oxidative stress [13].
In some pathological conditions, a reduction in NO bioavail-
ability contributes to the appearance of diseases such as athero-
sclerosis, myocardial infarction, coronary heart disease, and
hypertension [14–17]. It is important to emphasize that the
oxidative stress induced by cadmium might increase lipid perox-
idation [18,19], which in turn could induce atherosclerosis [4,5].
Additionally, cadmium affects the heart and blood vessels, causing
cardiovascular diseases such as hypertension [20] and cardiomyo-
pathy [21].
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One of the main sites affected by oxidative stress is the aorta,
which develops atherosclerosis. However, there are few reports
demonstrating vascular aortic effects induced by low cadmium
concentrations that are similar to those found in the blood after
occupational exposure. Furthermore, most of the studies were
conducted after chronic cadmium exposure, and the results of
these studies could therefore be inﬂuenced by secondary effects
induced by this metal, such as hypertension. Thus, we aimed to
evaluate the effects of acute exposure to Cd2þ on the vascular
reactivity of aortas isolated from rats and the possible mechanisms
underlying the oxidative stress involved in this process. For these
experiments, we used rat aortas incubated in vitro with 10 mM
CdCl2, a concentration that is similar to that measured in the aortic
tissues of humans who smoke [18,22].
Materials and methods
Animals
The studies were performed on 3-month-old male Wistar rats
(250–300 g). All the experiments were conducted in compliance
with the guidelines for biomedical research as stated by the
Brazilian Societies of Experimental Biology and approved by the
local ethics committee of the School of Sciences of Santa Casa de
Misericordia de Vitoria (004/2007 CEUA-EMESCAM). All the rats
had free access to water and rodent chow ad libitum.
Preparation of isolated rat aortas
Rats were anesthetized with sodium thiopental (50 mg/kg, ip)
and euthanized by exsanguination. Thoracic aortas were carefully
dissected out and cleaned of fat and connective tissue. For the
reactivity experiments, the aortas were divided into cylindrical
segments 4 mm in length (ﬁve to six rings per aorta). To analyze
the expression of the endothelial nitric oxide synthase (eNOS)
isoform, the phosphorylated endothelial nitric oxide synthase
(p-eNOSSer1177), and the AT1 protein, the arteries were rapidly frozen
in liquid nitrogen and kept at 70 1C until the day of analysis.
Vascular reactivity measurements
Segments of thoracic aorta were mounted in an isolated tissue
chamber containing Krebs–Henseleit buffer (in mmol  L1: NaCl
118, KCl 4.7, NaHCO3 23, CaCl2 2.5, KH2PO4 1.2, MgSO4 1.2, glucose
11, and EDTA 0.01) that had been gassed with 95% O2 and 5% CO2
(pH 7.4); the aortas were then maintained at a resting tension of 1 g
at 37 1C. The isometric tension was recorded using an isometric
force transducer (TSD125C, BIOPAC Systems, Santa Barbara, CA,
USA) connected to an acquisition system (MP100, BIOPAC Systems).
After a 45-min equilibration period, all the aortic rings were
initially exposed twice to 75 mM KCl, checked for functional
integrity, and assessed for the maximum tension developed.
Afterward, the endothelial integrity was tested with acetylcholine
(ACh; 10 mM) in segments that were previously contracted with
phenylephrine (10 mM). Relaxation equal to or greater than 90%,
before cadmium exposure, was considered demonstrative of the
functional integrity of the endothelium. After a washout period
(30 min), the aortic rings were incubated with cadmium chloride
(CdCl2; 10 mM) or buffer alone (control) for 45 min. Then, increas-
ing concentrations of phenylephrine (1010 to 3104 M) were
applied. A concentration–response curve for this contractile ago-
nist was obtained, and the tension was measured once a plateau
was attained.
The inﬂuence of the endothelium on the response to pheny-
lephrine in the absence or presence of cadmium was investigated
after the mechanical removal of the endothelium by rubbing the
lumen with a needle. The absence of the endothelium was
conﬁrmed by the inability of 10 mM ACh to produce relaxation.
The role of endothelial-derived vasoactive factors on the
phenylephrine-elicited contractile response was investigated. The
effects of the following drugs were evaluated: (1) the nonspeciﬁc
NOS inhibitor N-nitro-L-arginine methyl ester (L-NAME, 100 μM),
(2) an enzyme scavenger of reactive oxygen species (ROS; superoxide
dismutase (SOD), 150 Uml1), (3) an NADPH oxidase inhibitor
(apocynin, 0.3 mM), (4) a scavenger of hydrogen peroxide (catalase,
1000 Uml1), (5) co-incubation of catalase plus superoxide dismu-
tase, (6) an angiotensin-converting enzyme inhibitor (enalapril,
10 mM), (7) an angiotensin II type 1 receptor antagonist (losartan,
10 mM), (8) a cofactor for eNOS ((6R-)5,6,7,8-tetrahydro-L-biopterin
(BH4)), (9) a nonselective cyclooxygenase (COX) inhibitor (indo-
methacin, 10 mM), (10) a COX-2 inhibitor (NS 398, 1 mM), (11) a
thromboxane A2 synthase inhibitor (furegrelate, 1 mM), (12) the TP
receptor antagonist (thromboxane A2 receptor and prostaglandin H2;
SQ 29.548, 1 μM), and (13) an antagonist of the EP1 receptor (SC
19.220, 10 μM). These drugs were added 45 min before the genera-
tion of the phenylephrine concentration–response curves, in the
absence or presence of cadmium chloride (10 μM).
In another set of experiments, after the 45-min equilibration
period, the aortic rings incubated with or without cadmium
were contracted with phenylephrine (1 mM) until reaching a plateau
(approximately 15 min), and the concentration–response curves for
ACh (1010 to 3104 M) or sodium nitroprusside (SNP; 1010 to
3104 M) were obtained.
Western blot analysis of eNOS and AT1 expression
The eNOS, p-eNOSSer1177, and AT1 protein expression levels
were analyzed in homogenates from the aortic segments used for
the reactivity experiments (approximately 6 h after extraction
from the animal) that had been preincubated with or without
cadmium (for 45 min) as previously described [23].
Proteins from the homogenized arteries were separated by 7.5%
SDS–PAGE. The proteins were transferred to nitrocellulose mem-
branes that were then incubated with mouse monoclonal anti-
bodies for eNOS (1:250; Transduction Laboratories, BD, Lexington,
KY, USA), eNOS that was phosphorylated on the serine at position
1177 (p-eNOS Ser1177, 1:250; BD Transduction Laboratories, BD), or
AT1 (1:500, Santa Cruz Biotechnology, Santa Cruz, CA, USA). After
being washed, the membranes were incubated with an anti-
mouse or anti-rabbit (1:5000, StressGen, Victoria, BC, Canada)
immunoglobulin antibody conjugated to horseradish peroxidase.
After a thorough wash, the immunocomplexes were detected with
an enhanced horseradish peroxidase/luminol chemiluminescence
system (ECL, Amersham International, Little Chalfont, UK) and ﬁlm
(Hyperﬁlm ECL, Amersham International). The signals on the
immunoblot were quantiﬁed with the National Institutes of Health
ImageJ version 1.56 computer program. The same membrane was
used to examine α-actin expression using a mouse monoclonal
antibody (1:5000, Sigma–Aldrich, St. Louis, MO, USA).
Nitric oxide release
Nitric oxide release was measured as previously described [24].
The thoracic aorta segments were dissected and equilibrated for
30 min in Hepes buffer (in mmol  L1: NaCl 119, Hepes 20, CaCl2
1.2, KCl 4.6, MgSO4 1, KH2PO4 0.4, NaHCO3 5, glucose 5.5, NaH2PO4
0.15; pH 7.4) at 37 1C. The arteries were then incubated with the
ﬂuorescent probe 4,5-diaminoﬂuorescein (2 mmol  L1) for
30 min, and the medium was collected to measure the basal NO
release. The NO release was evaluated by measuring the release of
NO after incubation with or without cadmium for 45 min at 37 1C.
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The concentration–response curve for phenylephrine (1010 to
3104 M) was generated, and the ﬂuid was collected to measure
the stimulated NO production. The ﬂuorescence of the medium
was measured at room temperature using a spectroﬂuorimeter
(LS50 PerkinElmer Instruments, FL WINLAB software) with the
excitation wavelength set at 492 nm and the emission wavelength
set at 515 nm. Blank measurement samples were similarly col-
lected but without arteries to subtract the background emission.
The amount of NO released was expressed as arbitrary U mg1
tissue.
Drugs and reagents
Cadmium chloride, L-phenylephrine hydrochloride, L-NAME,
enalapril, indomethacin, acetylcholine chloride, sodium thiopen-
tal, losartan, apocynin, sodium nitroprusside, SOD, catalase, and
BH4 were purchased from Sigma–Aldrich. Furegrelate, NS 398, SQ
29.548, and SC 19.220 were purchased from Cayman Chemical
(Ann Arbor, MI, USA). When not speciﬁed, salts and reagents were
of analytical grade and were obtained from Sigma and Merck
(Darmstadt, Germany).
Statistical analyses
All the values are expressed as the mean7SEM. The contractile
responses are expressed as the percentage of the maximal
response induced by 75 mM KCl. The relaxation responses to
ACh or SNP are expressed as the percentage of relaxation of the
maximal contractile response. For each concentration–response
curve, the maximal effect (Rmax) and the concentration of agonist
that produced 50% of the maximal response (log EC50) were
calculated using nonlinear regression analysis (GraphPad Prism,
GraphPad Software, San Diego, CA, USA). The sensitivities of the
agonists were expressed as pD2 ( log EC50). To compare the
effects of modulating the endothelium and the effects of some
drugs on the contractile responses to phenylephrine, some results
are expressed as differences in the areas under the concentration–
response curves (dAUC) for the control and experimental groups.
These values indicate whether the magnitude of the effect of an
endothelial change is different between rats exposed or not
exposed to cadmium.
For the protein expression results, the data are expressed as the
ratio between signals on the immunoblot corresponding to the
protein of interest and α-actin. For the protein expression of p-
eNOSSer1177, the data are expressed as the ratio between p-
eNOSSer1177 and eNOS. The results are expressed as the mean7-
SEM of the number of rats indicated; differences were analyzed
using Student′s t test or a one-way ANOVA followed by a
Bonferroni test. Po0.05 was considered signiﬁcant.
Results
Effect of cadmium on vasoconstrictor and vasodilator responses
Exposure to cadmium increased the maximal response (Rmax)
induced by phenylephrine in the aortic rings compared to the
control (CT 102.473.4 vs Cd 136.976.25, Po0.05; Fig. 1A). How-
ever, the vasodilator responses induced by SNP and ACh were
unaffected by cadmium (Figs. 1B and C, respectively). The compar-
ison of the phenylephrine-induced precontraction before and after
cadmium exposure by measuring the developed tension (the
baseline level contractile response) showed that no signiﬁcant
Fig. 1. Concentration–response curves to (A) phenylephrine, (B) sodium nitroprusside (SNP), and (C) acetylcholine in control (CT) and cadmium-exposure (Cd) aortic rings.
nPo0.05 by Student′s t test. Number of animals used in parentheses.
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difference occurred (CT 1.8470.18 vs Cd 1.8670.21, n¼8; Student′s
t test, P40.05).
To evaluate the inﬂuence of the endothelium in this response,
we mechanically removed this tissue. The reactivity to pheny-
lephrine measured after the endothelium was damaged increased,
but this increase was smaller after the incubation with cadmium
(Figs. 2A and B). This difference is clearly seen when the dAUC are
compared (CT 147.9721.90 vs Cd 67.63719.04, Po0.05; Fig. 2C).
L-NAME was used to investigate the putative role of NO in the
effects produced by cadmium on the contractile responses induced
by phenylephrine. The concentration–response curve for pheny-
lephrine was left-shifted in the aortic segments from both groups
(with or without cadmium; Figs. 3A and B), but this effect was
smaller in the preparations from the cadmium-incubated rings
than in the controls, as indicated by the dAUC values (CT
101.32720.48 vs Cd 35.6076.63, Po0.05; Fig. 3C).
These results indicate that cadmium induces endothelial dys-
function in the conductance arteries, thereby reducing endothelial
NO modulation of the vasoconstrictor responses. Because altera-
tions in the levels of eNOS and p-eNOSSer1117 can produce
endothelial dysfunction, the expression of this protein was mea-
sured. Cadmium did not modify eNOS or p-eNOSSer1117 protein
expression in the aorta (Figs. 3D and E).
The role of free radicals in the effects of cadmium on the
phenylephrine response
To determine whether the endothelial changes observed in the
aortic rings after cadmium incubation were related to changes in
O2 production, the effects of the superoxide anion scavenger SOD
and the NADPH oxidase inhibitor apocynin on the vasoactive
responses were analyzed. SOD did not modify the vasoconstrictor
responses to phenylephrine in the control rat aortic segments, but
SOD reduced these responses in the cadmium-incubated rat aortic
segments (Rmax, SOD 80.776.0 vs CdþSOD 72.878.3, Po0.05;
Figs. 4A and B). Furthermore, a scavenger of hydrogen peroxide
was analyzed. Catalase did not modify the vasoconstrictor responses
to phenylephrine in the control rat aortic segments or in the
cadmium-incubated rat aortic segments (data not shown). Then, to
evaluate the effects of the superoxide anion on the vasoactive
responses, the combined effects of catalase and SOD were investi-
gated. The co-incubation effect (SOD plus catalase) was similar to the
effect of the incubation with SOD alone (Rmax, SOD 80.776.0 vs
SODþcatalase 71.4710.1; CdþSOD 72.878.3 vs CdþSODþcatalase
72.778.4; Po0.05; Figs. 4C and D). Apocynin, an inhibitor of NADPH
oxidase, reduced the phenylephrine responses in the aortic segments
from both groups (Figs. 5A and B), and this effect was greater in the
cadmium-incubated rat aortic segments, as indicated by the dAUC
values (CT 30.7277.10 vs Cd 62.4776.13, Po0.05; Fig. 5C).
To investigate decoupling, a cofactor of eNOS (BH4) was used.
BH4 did not change the reactivity to phenylephrine in the aortic
rings when cadmium was added (data not shown). This result
indicates that, although there was an increased production of free
radicals, eNOS was not decoupled.
The effect of exposure to cadmium on the local production
of nitric oxide
To strengthen the results found with the vascular reactivity
experiments, which suggest a reduction in NO bioavailability, we
measured the local production of this vasodilator and of super-
oxide in the aorta with chemiluminescence using the ﬂuorescent
probes 4,5-diaminoﬂuorescein and lucigenin, respectively. After
incubation with cadmium, the production and bioavailability of
NO were reduced after stimulation with phenylephrine and
incubation with Triton (Fig. 5D). Together, these results
indicate that cadmium induces endothelial dysfunction in con-
ductance arteries through an increase in the superoxide anion
Fig. 2. The effects of endothelium removal (E) on the concentration–response curves for phenylephrine in (A) control (CT) and (B) cadmium-exposure (Cd) aortic rings.
(C) Differences in area under the concentration–response curve (dAUC). nPo0.05 by Student′s t test. Number of animals used in parentheses.
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Fig. 4. SOD and SOD plus catalase effects on the concentration–response curves for phenylephrine in aortic rings under (A, C) control (CT) or (B, D) cadmium (Cd) conditions.
nPo0.05 by ANOVA. Number of animals used in parentheses.
Fig. 3. L-NAME effect on the concentration–response curves for phenylephrine in aortic rings under (A) control (CT) or (B) cadmium (Cd) conditions. (C) dAUC in the
presence and absence of L-NAME. Densitometry analyses of Western blots for (D) endothelial nitric oxide synthase (eNOS) and (E) phosphorylated eNOS (peNOS) protein
expression in aortas from CT and Cd aortic rings. Representative blots are also shown. nPo0.05 by Student′s t test. Number of animals used in parentheses.
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NADPH oxidase pathway, thereby reducing the bioavailability of
NO.
The role of the renin–angiotensin system in the effects of cadmium
on the phenylephrine response
To investigate whether the local renin–angiotensin system was
involved in the alterations of the vascular reactivity to pheny-
lephrine induced by cadmium, AT1 receptors and angiotensin-
converting enzyme activity were blocked with losartan (Los) and
enalapril (Ena), respectively. As shown in Figs. 6A–D, both drugs
partially reduced the effects of cadmium on the concentration–
response curve for phenylephrine (Rmax, Los 109.576.1, CdþLos
108.877.76, Ena 102.473.4, and CdþEna 119.575.0, Po0.05).
Thus, angiotensin II can stimulate NADPH oxidase and contribute
to the generation of oxidative stress.
To investigate further the involvement of the local renin–angio-
tensin system on the effects of cadmium, the expression of the
angiotensin AT1 receptor was evaluated. However, the expression of
AT1 did not change after an acute exposure to cadmium (Fig. 6E).
The role of the cyclooxygenase pathway in the effects of cadmium
on the phenylephrine response
To investigate the putative role of prostanoids on the enhanced
response to phenylephrine produced by cadmium, aortic rings
were incubated with indomethacin (INDO). The Rmax to pheny-
lephrine was reduced after cadmium incubation (Rmax, Cd
132.4073.77 vs Cdþ INDO 105.1677.10; Po0.05; Figs. 7A and
B), which suggests the involvement of vasoconstrictor prostanoids.
To clarify this issue, we investigated whether cyclooxygenase 2 or
thromboxane A2 was involved in the effects of cadmium. The
aortic rings were incubated with the COX-2 inhibitor NS 398, the
thromboxane A2 synthase inhibitor furegrelate, the TP receptor
antagonist SQ 29.548, or the EP1 receptor antagonist SC 19.220.
NS 398 reduced the vasoconstrictor responses to phenylephrine in
the control rat aortic segments and the segments after cadmium
incubation (Figs. 7C and D, respectively). However, the magnitude
of this effect was greater after incubation with cadmium, as
indicated by the dAUC (CT 120.09727.17 vs Cd 36.3175.93,
Po0.05; Fig. 7E). In addition, SC 19.220, SQ 29.548, and furegrelate
did not change the Rmax to phenylephrine in the untreated aortic
rings. However, the phenylephrine-induced maximal response
was reduced after incubation with cadmium (Rmax, Cd
140.85715.68, CdþSC 102.9077.60, CdþSQ 86.1179.49, and
CdþFure 70.7977.37, Po0.05), as shown in Fig. 8. Therefore,
we suggest that acute exposure to cadmium promotes the
increased production of vasoconstrictor prostanoids by COX-2,
including thromboxane A2 and prostaglandin H2, which contribute
to the increase in free radicals.
Discussion and conclusions
The major ﬁndings from this study demonstrate that acute
cadmium exposure alters the endothelial function of the conduc-
tance vessels by increasing O2 production. The consequence of
cadmium exposure is an increased vasoconstrictor response to
phenylephrine and a decreased NO endothelial modulation due to
a reduction in NO bioavailability. The administration of SOD and
apocynin reduced this increased vasoconstrictor response. The
results from pharmacological interventions with losartan, enala-
pril, indomethacin, NS 398, furegrelate, SQ 29.548, and SC 19.220
suggest that the renin–angiotensin system and COX-2 are involved
in the vascular effects of cadmium. Therefore, these results
demonstrate that acute cadmium exposure probably induces
endothelial dysfunction by a mechanism involving the increased
local release of angiotensin II and the increased activity of COX-2
and NADPH oxidase, which could contribute to the establishment
of atherosclerosis and hypertension.
Fig. 5. Apocynin (APO) effect on the concentration–response curves for phenylephrine in aortic rings under (A) control (CT) or (B) cadmium (Cd) conditions. (C) dAUC and
(D) curve release of nitric oxide. *Po0.05, **Po0.01 by Student′s t test. Number of animals used in parentheses.
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Humans and animals are exposed to cadmium via a variety of
routes, including industrial contamination, food sources, and tobacco
smoke [25]. Furthermore, the presence of cadmium in phosphate
fertilizers contributes to the increased incidence of cadmium poison-
ing in the general population because leafy vegetables, oilseeds, and
tobacco accumulate high levels of cadmium from the soil. Thus, food
and smoking are the main sources of nonoccupational exposure to
cadmium [1]. Tobacco smokers have approximately three times the
blood cadmium content than nonsmokers (1.58 μg L1 for smokers vs
0.47 μg L1 for nonsmokers) [2]. This content of cadmium in smokers
has been associated with an increased risk of hypertension and related
diseases [3]. Indeed, Ref. [18] demonstrated that the cadmium con-
centration in aortic tissue increases in direct proportion to tobacco
smoking. In this case, the cadmium concentration that was measured
in the middle layer of the aortic tissue of humans who smoke was
7 mmol L1 [18]. This concentrationwas sufﬁcient to induce a decrease
in the collagen content of this tissue.
Therefore, in this report, we demonstrated that the acute
administration of 10 mM Cd2þ , a concentration that is similar to
that measured in the aortic tissue of humans who smoke [18],
increases vascular reactivity in aortas isolated from rats, and we
examined the role of oxidative stress in this process.
The toxic vascular effects promoted by cadmium have been
attributed to the production of reactive oxygen species [26,27].
Cadmium is a redox-stable metal; therefore, radical production by
cadmium must be mediated through an indirect mechanism. The
mechanisms of acute cadmium toxicity may involve the depletion
of glutathione and protein-bound sulfhydryl groups, resulting in
the enhanced production of ROS, such as the superoxide ion,
hydrogen peroxide, and hydroxyl radicals [19,28].
Cadmium causes oxidative stress-induced endothelial dysfunction
[11,17,19,27]. Nolan and Shaikh [7] summarized earlier studies and
suggested that the vascular endothelium was a primary target for
cadmium and that the result was an increase in vascular reactivity in
Fig. 6. Enalapril (Ena) and losartan (Los) effects on the concentration–response curves for phenylephrine in aortic rings under (A, C) control (CT) or (B, D) cadmium (Cd)
conditions. (E) Densitometric analysis of the Western blot for AT1 in aortic rings under control conditions or cadmium. Representative blots are also shown. nP40.05 by
Student′s t test. Number of animals used in parentheses.
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a number of tissues. Additionally, it has been demonstrated that high
concentrations of cadmium and mercury cause oxidative damage,
including lipid peroxidation, DNA damage, and the depletion of
sulfhydryls [29]. Furthermore, cadmium induces increases in the
ROS superoxide and hydrogen peroxide through a reduced antiox-
idant defense [30].
The ability of mercury, cadmium, and other divalent metal ions
to cause toxicity to the cardiovascular system has long been
known [11,31,32]. However, the mechanism through which cad-
mium alters vascular function in conductance vessels requires a
better understanding. Because we are often exposed to this
particular cardiovascular risk factor, we used an in vitro cadmium
chloride (10 mM) exposure to clarify the mechanisms that are
promoted by this metal that may be involved in the development
of cardiovascular diseases.
The estimated daily intake of cadmium in nonsmoking adult
males and females living in the United States is 0.35 and 0.30 μg
Cd/kg/day, respectively. However, the major route of exposure is
through the inhalation of dust and fumes or accidental ingestion
from contaminated hands, food, or cigarettes [33]. The provisional
tolerable weekly intake for cadmium is 7 μg/kg body wt, which
translates to 70 μg/day for a person who weighs 70 kg. However,
smoking greatly increases exposure to cadmium because tobacco
leaves naturally accumulate large amounts of cadmium. Tobacco
smokers are exposed to an estimated 1.7 μg cadmium per cigar-
ette, and approximately 10% is inhaled when smoked. The geo-
metric mean blood cadmium level for a heavy smoker has been
reported to be as high as 1.58 μg/L, compared to the estimated
American mean of 0.47 μg/L for all adults. Nonsmokers may also
be exposed to cadmium in cigarettes via second-hand smoke [33].
In this study, we observed that the acute administration
of cadmium promoted an increase in the reactivity to phenylephr-
ine in aortic rings. However, when comparing the dAUC% of aortic
rings with and without endothelium, we observed that the
magnitude of the response to phenylephrine was lower after the
cadmium incubation in the aortic rings denuded of endothelium.
These results suggest that the ability of the endothelium to
negatively modulate the contractile response induced by pheny-
lephrine may be impaired in the isolated aortic rings incubated
with cadmium. The increased vascular reactivity to phenylephrine
and the concomitant reduction of endothelial modulation after
incubation with cadmium in the aortic rings could be a conse-
quence of reduced NO bioavailability [34].
Comparing the Emax values of the aortic rings with damaged
endothelium (E) for the control and cadmium-exposed samples,
the tension level achieved was the same (Emax control 177.173.8%
vs Cd 160.177.0%; n¼8, P40.05). This result suggests that the
smooth muscle was fully activated in both situations, which explains
the lack of a difference. Another explanation, although speculative,
is that the calcium inﬂux was not affected by the cadmium concen-
tration used. This possibility is reinforced by the fact that the
phenylephrine-induced contractions were similar before and after
cadmium exposure. Regarding the increased sensitivity, our results
suggest that the reduced endothelial modulation (see Fig. 3) is the
mechanism by which the sensitivity is increased.
L-NAME was used to investigate the putative role of NO in the
effects produced by cadmium on the contractile responses induced
by phenylephrine. The results indicate that cadmium incubation
induces endothelial dysfunction in conductance arteries, thereby
reducing the endothelial-induced NO modulation of the vasocon-
strictor responses.
Furthermore, our results revealed that treatment with SOD or
apocynin reversed the effects of cadmium on the vascular reactiv-
ity to phenylephrine in the aortic rings, suggesting that acute
exposure to cadmium is accompanied by an increased production
of ROS. Additionally, after an incubation with the metal, the
production and bioavailability of NO were reduced after stimula-
tion with phenylephrine and incubation with Triton. Therefore, we
Fig. 7. Indomethacin (INDO) and NS 398 effects on the concentration–response curves for phenylephrine in aortic rings under (A, C) control (CT) or (B, D) cadmium (Cd)
conditions. (E) dAUC in aortic rings in the presence of NS 398. nPo0.05 by Student′s t test. Number of animals used in parentheses.
J.K. Angeli et al. / Free Radical Biology and Medicine 65 (2013) 838–848 845
suggest that the increased vascular reactivity to phenylephrine
induced by cadmium may be caused by an increased release of
ROS, resulting in the reduced bioavailability of NO.
The main factor that contributes to the reduction in NO
bioavailability is the increase in ROS. The superoxide anion
interacts with NO and forms peroxynitrite, thereby decreasing
NO bioavailability for smooth muscle relaxation [35]. Thus, the
reduced NO bioavailability induced by cadmium may be related to
the increased levels of ROS. The increased superoxide anion
production is due to stimulation of NADPH oxidase, xanthine
oxidase, uncoupled eNOS [36–38], or the reduction of antioxidant
defenses [39]. The maintenance of oxidative stress may lead to
endothelial damage and vascular disease [36,38,40].
A previous report revealed that an increase in the activity of the
local renin–angiotensin system and the production of prostanoid
vasoconstrictors increases the level of ROS in the aortas of
normotensive (WKY) and spontaneously hypertensive rats (SHR)
[23]. Therefore, we investigated whether the vascular actions
induced by cadmium involved the renin–angiotensin system. The
enalapril-blocking effects suggest that cadmium stimulates
angiotensin-converting enzyme activity, generating more angio-
tensin II, which is blocked by losartan. In addition, angiotensin II
regulates COX-2 protein expression, the production of prostanoids
[23,38,41], and NADPH oxidase activity [42].
Prostanoids are known regulators of vascular tone. To assess the
participation of prostanoids, we used indomethacin, which would
indicate whether vasoconstrictor prostanoids were involved. NS
398, SQ 29.548, SC 19.220, and furegrelate reduced the vasocon-
strictor responses to phenylephrine in both the control aortic
segments from rats and the segments after cadmium incubation.
Fig. 8. SC 19.220 (SC), SQ 29.548 (SQ), and furegrelate (Fure) effects on the concentration–response curves for phenylephrine in aortic rings under (A, C, E) control (CT) or
(B, D, F) cadmium (Cd) conditions. nPo0.05 by Student′s t test. Number of animals used in parentheses.
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However, the magnitude of this effect was greater after incubation
with cadmium. These results suggest that vasoconstrictor prosta-
noids, speciﬁcally thromboxane A2, participate in the increased
reactivity to phenylephrine induced by cadmium. Thus, the
increased local release of angiotensin II induced by cadmium could
cause the increased activity of COX-2 and NADPH oxidase, which
could then increase the release of ROS, as observed in this study
[23,31,42,43]. Together, these factors may contribute to the vascular
hyperactivity to phenylephrine induced by this metal.
It is important to emphasize that the present ﬁndings reinforce
the biological signiﬁcance of cadmium as an environmental con-
taminant that damages the human organism by producing harm-
ful effects to the cardiovascular system. The ﬁndings obtained thus
far must be interpreted with consideration of some limitations.
When studying the COX action on the effects of cadmium, we did
not use a speciﬁc COX-1 inhibitor. Indomethacin, a nonspeciﬁc
inhibitor, was used to address this issue in addition to a speciﬁc
COX-2 inhibitor. However, we cannot discard the participation of a
COX-1-derived compound, which can act as a vasodilator or a
vasoconstrictor, depending on the amount produced [44].
Another issue to be considered is the involvement of inducible
NOS in the vascular response to cadmium. Although we did not
test this involvement in our study, it has already been reported
that there is a relationship between inducible NOS and vasocon-
strictor responses [45].
Therefore, acute cadmium toxicity, which could induce
endothelial dysfunction, may increase vascular inﬂammation and
atherosclerosis. Taken together, these results suggest that acute
exposure to cadmium triggers the production of ROS that, when
occurring repeatedly, may initiate an inﬂammatory process and
atherosclerosis development in the aorta.
In summary, our results indicate that in vitro exposure to
cadmium increased vascular reactivity to phenylephrine, possibly
as the result of reduced NO bioavailability due to the increased
release of ROS. The increased release of ROS derived from NADPH
oxidase may be due to the increased local release of angiotensin II
and the release of vasoconstrictor prostanoids derived from the
COX-2 pathway. Therefore, a repeated acute cadmium exposure,
time after time, could induce endothelial dysfunction and con-
tribute to an increased peripheral resistance and consequently to
the genesis and maintenance of hypertension, thus reinforcing the
suggestion that cadmium exposure is a high risk to public health.
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